Koc, I. Et Al. 2018. Real-World Results of Intravitreal Ranibizumab, Bevacizumab, or Triamcinolone for Diabetic Macular Edema. OPHTHALMOLOGICA , vol.239 , 85-93.

Koc, I., KADAYIFÇILAR, S., & Eldem, B., (2018). Real-World Results of Intravitreal Ranibizumab, Bevacizumab, or Triamcinolone for Diabetic Macular Edema. OPHTHALMOLOGICA , vol.239, 85-93.

Koc, İREM, SİBEL KADAYIFÇILAR, And Bora Eldem. "Real-World Results of Intravitreal Ranibizumab, Bevacizumab, or Triamcinolone for Diabetic Macular Edema," OPHTHALMOLOGICA , vol.239, 85-93, 2018

Koc, İREM Et Al. "Real-World Results of Intravitreal Ranibizumab, Bevacizumab, or Triamcinolone for Diabetic Macular Edema." OPHTHALMOLOGICA , vol.239, pp.85-93, 2018

Koc, I. KADAYIFÇILAR, S. And Eldem, B. (2018) . "Real-World Results of Intravitreal Ranibizumab, Bevacizumab, or Triamcinolone for Diabetic Macular Edema." OPHTHALMOLOGICA , vol.239, pp.85-93.

@article{article, author={İREM KOÇ Et Al. }, title={Real-World Results of Intravitreal Ranibizumab, Bevacizumab, or Triamcinolone for Diabetic Macular Edema}, journal={OPHTHALMOLOGICA}, year=2018, pages={85-93} }